A Urine-Based Liquid Biopsy Method for Detection of Upper Tract Urinary Carcinoma
BackgroundConventional clinical detection methods such as CT, urine cytology, and ureteroscopy display low sensitivity and/or are invasive in the diagnosis of upper tract urinary carcinoma (UTUC), a factor precluding their use. Previous studies on urine biopsy have not shown satisfactory sensitivity...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-02-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.597486/full |
| _version_ | 1818611143224066048 |
|---|---|
| author | Yansheng Xu Yansheng Xu Xin Ma Xing Ai Jiangping Gao Yiming Liang Qin Zhang Tonghui Ma Kaisheng Mao Qiaosong Zheng Sizhen Wang Yuchen Jiao Xu Zhang Hongzhao Li |
| author_facet | Yansheng Xu Yansheng Xu Xin Ma Xing Ai Jiangping Gao Yiming Liang Qin Zhang Tonghui Ma Kaisheng Mao Qiaosong Zheng Sizhen Wang Yuchen Jiao Xu Zhang Hongzhao Li |
| author_sort | Yansheng Xu |
| collection | DOAJ |
| description | BackgroundConventional clinical detection methods such as CT, urine cytology, and ureteroscopy display low sensitivity and/or are invasive in the diagnosis of upper tract urinary carcinoma (UTUC), a factor precluding their use. Previous studies on urine biopsy have not shown satisfactory sensitivity and specificity in the application of both gene mutation or gene methylation panels. Therefore, these unfavorable factors call for an urgent need for a sensitive and non-invasive method for the diagnosis of UTUC.MethodsIn this study, a total of 161 hematuria patients were enrolled with (n = 69) or without (n = 92) UTUC. High-throughput sequencing of 17 genes and methylation analysis for ONECUT2 CpG sites were combined as a liquid biopsy test panel. Further, a logistic regression prediction model that contained several significant features was used to evaluate the risk of UTUC in these patients.ResultsIn total, 86 UTUC− and 64 UTUC+ case samples were enrolled for the analysis. A logistic regression analysis of significant features including age, the mutation status of TERT promoter, and ONECUT2 methylation level resulted in an optimal model with a sensitivity of 94.0%, a specificity of 93.1%, the positive predictive value of 92.2% and a negative predictive value of 94.7%. Notably, the area under the curve (AUC) was 0.957 in the training dataset while internal validation produced an AUC of 0.962. It is worth noting that during follow-up, a patient diagnosed with ureteral inflammation at the time of diagnosis exhibiting both positive mutation and methylation test results was diagnosed with ureteral carcinoma 17 months after his enrollment.ConclusionThis work utilized the epigenetic biomarker ONECUT2 for the first time in the detection of UTUC and discovered its superior performance. To improve its sensitivity, we combined the biomarker with high-throughput sequencing of 17 genes test. It was found that the selected logistic regression model diagnosed with ureteral cancer can evaluate upper tract urinary carcinoma risk of patients with hematuria and outperform other existing panels in providing clinical recommendations for the diagnosis of UTUC. Moreover, its high negative predictive value is conducive to rule to exclude patients without UTUC. |
| first_indexed | 2024-12-16T15:25:38Z |
| format | Article |
| id | doaj.art-b62e9de2f85f40f7b93fdcb19c00813d |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-16T15:25:38Z |
| publishDate | 2021-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-b62e9de2f85f40f7b93fdcb19c00813d2022-12-21T22:26:30ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-02-011010.3389/fonc.2020.597486597486A Urine-Based Liquid Biopsy Method for Detection of Upper Tract Urinary CarcinomaYansheng Xu0Yansheng Xu1Xin Ma2Xing Ai3Jiangping Gao4Yiming Liang5Qin Zhang6Tonghui Ma7Kaisheng Mao8Qiaosong Zheng9Sizhen Wang10Yuchen Jiao11Xu Zhang12Hongzhao Li13Department of Urology, The First Medical Center of Chinese PLA General Hospital, Beijing, ChinaDepartment of Urology, The Sixth Medical Center of Chinese PLA General Hospital, Beijing, ChinaDepartment of Urology, The First Medical Center of Chinese PLA General Hospital, Beijing, ChinaDepartment of Urology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, ChinaDepartment of Urology, The Fourth Medical Center of Chinese PLA General Hospital, Beijing, ChinaGenetron Health (Beijing) Technology, Co. Ltd., Beijing, ChinaGenetron Health (Beijing) Technology, Co. Ltd., Beijing, ChinaGenetron Health (Beijing) Technology, Co. Ltd., Beijing, ChinaGenetron Health (Beijing) Technology, Co. Ltd., Beijing, ChinaGenetron Health (Beijing) Technology, Co. Ltd., Beijing, ChinaGenetron Health (Beijing) Technology, Co. Ltd., Beijing, ChinaState Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Urology, The First Medical Center of Chinese PLA General Hospital, Beijing, ChinaDepartment of Urology, The First Medical Center of Chinese PLA General Hospital, Beijing, ChinaBackgroundConventional clinical detection methods such as CT, urine cytology, and ureteroscopy display low sensitivity and/or are invasive in the diagnosis of upper tract urinary carcinoma (UTUC), a factor precluding their use. Previous studies on urine biopsy have not shown satisfactory sensitivity and specificity in the application of both gene mutation or gene methylation panels. Therefore, these unfavorable factors call for an urgent need for a sensitive and non-invasive method for the diagnosis of UTUC.MethodsIn this study, a total of 161 hematuria patients were enrolled with (n = 69) or without (n = 92) UTUC. High-throughput sequencing of 17 genes and methylation analysis for ONECUT2 CpG sites were combined as a liquid biopsy test panel. Further, a logistic regression prediction model that contained several significant features was used to evaluate the risk of UTUC in these patients.ResultsIn total, 86 UTUC− and 64 UTUC+ case samples were enrolled for the analysis. A logistic regression analysis of significant features including age, the mutation status of TERT promoter, and ONECUT2 methylation level resulted in an optimal model with a sensitivity of 94.0%, a specificity of 93.1%, the positive predictive value of 92.2% and a negative predictive value of 94.7%. Notably, the area under the curve (AUC) was 0.957 in the training dataset while internal validation produced an AUC of 0.962. It is worth noting that during follow-up, a patient diagnosed with ureteral inflammation at the time of diagnosis exhibiting both positive mutation and methylation test results was diagnosed with ureteral carcinoma 17 months after his enrollment.ConclusionThis work utilized the epigenetic biomarker ONECUT2 for the first time in the detection of UTUC and discovered its superior performance. To improve its sensitivity, we combined the biomarker with high-throughput sequencing of 17 genes test. It was found that the selected logistic regression model diagnosed with ureteral cancer can evaluate upper tract urinary carcinoma risk of patients with hematuria and outperform other existing panels in providing clinical recommendations for the diagnosis of UTUC. Moreover, its high negative predictive value is conducive to rule to exclude patients without UTUC.https://www.frontiersin.org/articles/10.3389/fonc.2020.597486/fullhematurialiquid biopsynext-generation sequencingmethylationupper tract urinary carcinomalogistic regression model |
| spellingShingle | Yansheng Xu Yansheng Xu Xin Ma Xing Ai Jiangping Gao Yiming Liang Qin Zhang Tonghui Ma Kaisheng Mao Qiaosong Zheng Sizhen Wang Yuchen Jiao Xu Zhang Hongzhao Li A Urine-Based Liquid Biopsy Method for Detection of Upper Tract Urinary Carcinoma Frontiers in Oncology hematuria liquid biopsy next-generation sequencing methylation upper tract urinary carcinoma logistic regression model |
| title | A Urine-Based Liquid Biopsy Method for Detection of Upper Tract Urinary Carcinoma |
| title_full | A Urine-Based Liquid Biopsy Method for Detection of Upper Tract Urinary Carcinoma |
| title_fullStr | A Urine-Based Liquid Biopsy Method for Detection of Upper Tract Urinary Carcinoma |
| title_full_unstemmed | A Urine-Based Liquid Biopsy Method for Detection of Upper Tract Urinary Carcinoma |
| title_short | A Urine-Based Liquid Biopsy Method for Detection of Upper Tract Urinary Carcinoma |
| title_sort | urine based liquid biopsy method for detection of upper tract urinary carcinoma |
| topic | hematuria liquid biopsy next-generation sequencing methylation upper tract urinary carcinoma logistic regression model |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2020.597486/full |
| work_keys_str_mv | AT yanshengxu aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT yanshengxu aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT xinma aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT xingai aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT jiangpinggao aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT yimingliang aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT qinzhang aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT tonghuima aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT kaishengmao aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT qiaosongzheng aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT sizhenwang aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT yuchenjiao aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT xuzhang aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT hongzhaoli aurinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT yanshengxu urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT yanshengxu urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT xinma urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT xingai urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT jiangpinggao urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT yimingliang urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT qinzhang urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT tonghuima urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT kaishengmao urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT qiaosongzheng urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT sizhenwang urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT yuchenjiao urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT xuzhang urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma AT hongzhaoli urinebasedliquidbiopsymethodfordetectionofuppertracturinarycarcinoma |